Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Fingertip Blood Test Accurately Diagnoses Tuberculosis in Children

By LabMedica International staff writers
Posted on 01 Nov 2023

Every year, tuberculosis claims the lives of approximately 240,000 children globally, making it one of the leading causes of death for kids under five. More...

A key issue contributing to these numbers is the frequent failure to diagnose the disease correctly or in a timely manner, especially in resource-limited settings. Traditional methods for diagnosing tuberculosis generally rely on microbiological analysis of sputum, or mucus collected from the lower airways. This is a challenge in children, who often have a low bacterial count in their sputum and show nonspecific symptoms. Now, a new diagnostic tool makes it easier to diagnose tuberculosis in children by requiring just a fingertip blood sample.

An international research consortium led by medical scientists at LMU University Hospital Munich (Munich, Germany) conducted extensive testing of this new diagnostic method in a large study spanning five countries. The tool operates on the basis of the activity of three specific genes measurable in capillary blood. Using an innovative semi-automatic system, healthcare providers can identify a transcriptomic signature for these genes, which aids in diagnosing tuberculosis. A significant advantage of this test is its convenience: the blood sample can be taken effortlessly from a fingertip, and the results are available in just over an hour. This is much faster than most other tests, which often require sending samples to specialized labs for analysis.

The new tool was evaluated during the RaPaed-TB tuberculosis study, conducted in collaboration with partners in South Africa, Mozambique, Tanzania, Malawi, and India. The study involved 975 children under the age of 15 who were suspected of having tuberculosis. To assess the test's accuracy, the children's tuberculosis status was also examined using a standardized reference test based on sputum analysis and bacterial cultures. Given that the reference signature for the new tool was mostly derived from adult samples, the researchers believe that the accuracy of the test can be enhanced further by fine-tuning the signature calculation for children.

“The results were encouraging,” said LMU medical scientist Laura Olbrich. “Compared to detection in culture, the test identified almost 60 percent of children with tuberculosis, with 90-percent specificity. This makes the test comparable with or better than all other tests that work with biomarkers. The bacterial culture is always the reference because it yields the most stable results. But it takes up to eight weeks and is often not available where children with tuberculosis present.”

Related Links:
LMU University Hospital Munich 


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.